alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Use este anexo para mostrar su OBLIGACIÓN CONTRIBUTIVA para el trimestre: por favor, NO LO USE para mostrar sus depósitos de

contribución. Debe llenar esta planilla y adjuntarla a la Forma 941-PR si usted es un(a) depositante de itinerario bisemanal o si su obligación

contributiva acumulada en cualquier día asciende a $100,000 ó más. Escriba sus obligaciones contributivas en el espacio numerado que

corresponda a la fecha en la cual se pagaron los salarios. Vea el apartado 11 de la Publicación 179 (Circular PR) para más detalles.

16

Registro de la Obligación Contributiva para los Depositantes de Itinerario Bisemanal

Department of the Treasury — Internal Revenue Service

1

2

3

4

5

6

7

8

Obligación contributiva

para el Mes 1

Para el Aviso sobre la Ley de Reducción de Trámites, vea las

instrucciones por separado.

Cat. No. 12465Z Anexo B (Forma 941-PR) (Rev. 1-2006)

Obligación total para el 

trimestre

Escriba el total de su obligación contributiva para el trimestre (Mes 1 +

Mes 2 + Mes 3) = Total de su obligación contributiva para el trimestre

(Ese total debe = la línea 8 de la Forma 941-PR)



9

10

11

12

13

14

15

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

Mes 1

Obligación contributiva

para el Mes 2

Obligación contributiva

para el Mes 3

. .

.

.

.

OMB No. 1545-0029

Informe para este trimestre...

(Marque uno.)

1: enero, febrero, marzo

2: abril, mayo, junio

3: julio, agosto, septiembre

4: octubre, noviembre, diciembre

Anexo B (Forma 941-PR):

Mes 2

Mes 3

Número de identificación

del patrono (EIN)

Nombre (el de usted, no

el de su negocio)

—

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

16

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

16

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

(Rev. enero del 2006)

Año calendario (natural) (Marque también el trimestre a la derecha.)
<TABLE> <S> <C>

<ARTICLE> 9
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM 1998 FIRST
QUARTER 10-Q
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               MAR-31-1998
<CASH>                                           2,959
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                 1,250
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                      6,872
<INVESTMENTS-CARRYING>                           7,171
<INVESTMENTS-MARKET>                             7,380
<LOANS>                                         63,705
<ALLOWANCE>                                      1,034
<TOTAL-ASSETS>                                  84,410
<DEPOSITS>                                      65,992
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                              1,324
<LONG-TERM>                                      6,684
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         2,975
<OTHER-SE>                                       7,435
<TOTAL-LIABILITIES-AND-EQUITY>                  84,410
<INTEREST-LOAN>                                  1,361
<INTEREST-INVEST>                                  259
<INTEREST-OTHER>                                     0
<INTEREST-TOTAL>                                 1,620
<INTEREST-DEPOSIT>                                 613
<INTEREST-EXPENSE>                                 707
<INTEREST-INCOME-NET>                              913
<LOAN-LOSSES>                                      (8)
<SECURITIES-GAINS>                                (13)
<EXPENSE-OTHER>                                    617
<INCOME-PRETAX>                                    425
<INCOME-PRE-EXTRAORDINARY>                         425
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       303
<EPS-PRIMARY>                                     0.51
<EPS-DILUTED>                                     0.51
<YIELD-ACTUAL>                                    4.79
<LOANS-NON>                                         10
<LOANS-PAST>                                        99
<LOANS-TROUBLED>                                    11
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                 1,035
<CHARGE-OFFS>                                        1
<RECOVERIES>                                         8
<ALLOWANCE-CLOSE>                                1,034
<ALLOWANCE-DOMESTIC>                                85
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                            949
        

</TABLE>
Filed by Automated Filing Services Inc. (604) 609-0244 - Medicure Inc. - Exhibit 4 (t)







	M E D I C U R E   I N T E R N A T I O N A
      L   I N C . 


July 4, 2006

MEDICURE INTERNATIONAL INC., 
a corporation
incorporated under the laws of Barbados, 
(hereinafter referred to as
"Medicure"),

- and -

Clinical Development Research Institute Inc. 
a
corporation incorporated under the laws of Canada, 
(hereinafter referred to
as "Development Co").

Re: Amendment to the Development Agreement (the
“Agreement”)

This letter, once executed, will constitute an amendment to the
Agreement dated July 5, 2004. The wording of Section 3.1 (b) of the Agreement,
dated July 5, 2004 is hereby replaced with the following:

“The aggregate of all Expenditure Limits under all Research
Schedules entered into pursuant to this Agreement shall not exceed thirty
million dollars ($30,000,000) (the “Aggregate Expenditures”).”

In addition the Expenditure Limit as defined in Schedule B of
the Agreement is increased to $30,000,000.

All other terms, covenants and conditions remain in force in
accordance with the original agreement as dated July 5, 2004.

Upon execution of the agreement, please return one original to
our office and retain the other for your files.


  	MEDICURE INTERNATIONAL INC. 	 	 CDRI INC. 
	  	  	 	  	  
	Per: 	/s/ Trevor Hassell 	 	Per: 	/s/ Jim Charlton 
	  	Name: Trevor Hassell 	 	  	Name: Jim Charlton 
	  	Position: Director 	 	  	Position: President 
	  	 	 	  	  
	MEDICURE INTERNATIONAL INC. 	 	  	  
	  	 	 	  	  
	Per: 	/s/ Kirk Cyrus 	 	  	  
	  	Name: Kirk Cyrus 	 	  	  
	  	Position: Treasurer
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-END>                               SEP-30-1995
<CASH>                                       4,038,223
<SECURITIES>                                         0
<RECEIVABLES>                                  166,093
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             4,204,316
<PP&E>                                      20,846,160
<DEPRECIATION>                              16,051,553
<TOTAL-ASSETS>                               9,296,541
<CURRENT-LIABILITIES>                        1,338,958
<BONDS>                                              0
<COMMON>                                             0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                   7,957,583
<TOTAL-LIABILITY-AND-EQUITY>                 9,296,541
<SALES>                                      4,239,127
<TOTAL-REVENUES>                             5,503,440
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             3,550,738
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              1,952,702
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          1,952,702
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,952,702
<EPS-PRIMARY>                                    64.86
<EPS-DILUTED>                                    64.86
        

</TABLE>
Douglas

instance NRS 34.724(2)(b); NRS 34.738(1). Accordingly, we

ORDER the petition DENIED.

Parraguirre

cc: Kamario Mantrell Smith Attorney General/Carson City Eighth District Court Clerk

'We express no opinion as to whether petitioner could meet the procedural requirements of NRS chapter 34.

SUPREME COURT

OF NEVADA 2 (0) I947A
Exhibit 31.2

**CERTIFICATION**

I, Daniel E. Hamilton, the Chief Financial Officer of Crystallex International Corporation (the “Company”), certify that:

1. I have reviewed this amendment to annual report on Form 40-F/A – No. 1 for the year ended December 31, 2005, of the Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

Date: June 15, 2006 

/s/ Daniel E. HamiltonDaniel E. HamiltonChief Financial Officer

----
<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000912263
<NAME> THE TALBOTS, INC.
<MULTIPLIER> 1,000
<CURRENCY> US DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          JAN-30-1999
<PERIOD-START>                             FEB-01-1998
<PERIOD-END>                               JAN-30-1999
<EXCHANGE-RATE>                                      1
<CASH>                                          20,195
<SECURITIES>                                         0
<RECEIVABLES>                                  100,825
<ALLOWANCES>                                     1,600
<INVENTORY>                                    175,678
<CURRENT-ASSETS>                               339,915
<PP&E>                                         189,510
<DEPRECIATION>                                 193,144
<TOTAL-ASSETS>                                 657,064
<CURRENT-LIABILITIES>                          138,394
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           353
<OTHER-SE>                                     401,720
<TOTAL-LIABILITY-AND-EQUITY>                   657,064
<SALES>                                      1,142,246
<TOTAL-REVENUES>                             1,142,246
<CGS>                                          749,112
<TOTAL-COSTS>                                1,075,315
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               7,308
<INCOME-PRETAX>                                 59,623
<INCOME-TAX>                                    22,955
<INCOME-CONTINUING>                             36,668
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    36,668
<EPS-PRIMARY>                                     1.15
<EPS-DILUTED>                                     1.15
        

</TABLE>
EXHIBIT 31

                                  CERTIFICATION
            Pursuant to Section 302 of the Sarbanes Oxley Act of 2002

I, Mark Woodburn, certify that:

1.   I have reviewed this annual report on Form 10-KSB of Natural Health Trends
     Corp.;

2.   Based on my knowledge, this report does not contain any untrue statement of
     a material fact or omit to state a material fact necessary to make the
     statements made, in light of the circumstances under which such statements
     were made, not misleading with respect to the period covered by this
     report;

3.   Based on my knowledge, the financial statements, and other financial
     information included in this report, fairly present in all material
     respects the financial condition, results of operations and cash flows of
     the registrant as of, and for, the periods presented in this report;

4.   I am responsible for establishing and maintaining disclosure controls and
     procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for
     the registrant and have:

     a)   designed such disclosure controls and procedures, or caused such
          disclosure controls and procedures to be designed under my
          supervision, to ensure that material information relating to the
          registrant, including its consolidated subsidiaries, is made known to
          me by others within those entities, particularly during the period in
          which this report is being prepared;

     b)   Evaluated the effectiveness of the registrant's disclosure controls
          and procedures and presented in this report my conclusions about the
          effectiveness of the disclosure controls and procedures, as of the end
          of the period covered by this report based on such evaluation; and

     c)   Disclosed in this report any change in the registrant's internal
          control over financial reporting that occurred during the registrant's
          most recent fiscal quarter (the registrant's fourth fiscal quarter in
          the case of an annual report) that has materially affected, or is
          reasonably likely to materially affect, the registrant's internal
          control over financial reporting; and

5.   The registrant's I have disclosed, based on my most recent evaluation of
     internal control over financial reporting, to the registrant's auditors and
     the audit committee of the registrant's board of directors (or persons
     performing the equivalent functions):

     a)   all significant deficiencies and material weaknesses in the design or
          operation of internal control over financial reporting which are
          reasonably likely to adversely affect the registrant's ability to
          record, process, summarize and report financial information; and

     b)   any fraud, whether or not material, that involves management or other
          employees who have a significant role in the registrant's internal
          control over financial reporting.

Date: April 13, 2004

/s/ MARK WOODBURN
-------------------------------------
Mark Woodburn
President and Chief Financial Officer
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
QUARTERLY REPORT 10-Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0000829092
<NAME> MARRIOTT RESIDENCE INN LIMITED PARTNERSHIP
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLAR
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               JUN-20-1997
<EXCHANGE-RATE>                                   1.00
<CASH>                                           3,802
<SECURITIES>                                         0
<RECEIVABLES>                                    2,651
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 5,254
<PP&E>                                         196,558
<DEPRECIATION>                                (57,200)
<TOTAL-ASSETS>                                 151,065
<CURRENT-LIABILITIES>                           23,968
<BONDS>                                        122,097
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                       5,000
<TOTAL-LIABILITY-AND-EQUITY>                   151,065
<SALES>                                              0
<TOTAL-REVENUES>                                14,674
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 7,249
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               6,089
<INCOME-PRETAX>                                  1,336
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,336
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Federal Emergency Management Agency

          - [FEMA-3162-EM] 

# AGENCY:

Federal Emergency Management Agency (FEMA). 

# ACTION:

Notice. 

# SUMMARY:

This notice amends the notice of an emergency declaration for the State of Indiana, (FEMA-3162-EM), dated January 24, 2001, and related determinations. 

# EFFECTIVE DATE:

February 6, 2001. 

# FOR FURTHER INFORMATION CONTACT:

Madge Dale, Response and Recovery Directorate, Federal Emergency Management Agency, Washington, DC 20472, (202) 646-3772. 

# SUPPLEMENTARY INFORMATION:

The notice of an emergency declaration for the State of Indiana is hereby amended to include the following areas among those areas determined to have been adversely affected by the catastrophe declared an emergency by the President in his declaration of January 24, 2001: 

The Counties of Adams, Benton, DeKalb, Grant, LaPorte, Marshall, Newton, Porter, Starke, Wabash, and Wells for emergency protective measures under the Public Assistance program for a period of 48 hours. 

(The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 83.537, Community Disaster Loans; 83.538, Cora Brown Fund Program; 83.539, Crisis Counseling; 83.540, Disaster Legal Services Program; 83.541, Disaster Unemployment Assistance (DUA); 83.542, Fire Suppression Assistance; 83.543, Individual and Family Grant (IFG) Program; 83.544, Public Assistance Grants; 83.545, Disaster Housing Program; 83.548, Hazard Mitigation Grant Program.)

Lacy E. Suiter, 

Executive Associate Director, Response and Recovery Directorate. 

[FR Doc. 01-4128 Filed 2-16-01; 8:45 am] 

BILLING CODE 6718-02-P
Exhibit 99.1

**CERTIFICATION PURSUANT TO  18 U.S.C. SECTION 1350,  AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of American Retirement Villas Properties II, a California limited partnership (the “Partnership”)on Form 10-Q for the period ended June 30, 2002 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Douglas M. Pasquale, Chief Executive Officer of the General Partner of the Partnership, certify,pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

          (1)          The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities ExchangeAct of 1934; and

          (2)          The information contained in the Report fairly presents, inall material respects, the financial condition and result of operations of the Partnership.

| /s/ DOUGLAS M. PASQUALE |  
 
**Douglas M. Pasquale Chief Executive Officer of ARV Assisted Living, Inc. its General Partner**

 
 
 
**November 13, 2002**

  |
|-------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Fourth Court of Appeals

San Antonio, Texas

November 18, 2022

No. 04-22-00072-CV

JMI CONTRACTORS, LLC,

Appellant

v.

Jose Manuel MEDELLIN,

Appellee

From the 285th Judicial District Court, Bexar County, Texas

Trial Court No. 2018-CI-05983

Honorable Aaron Haas, Judge Presiding

O R D E R

Appellant’s reply brief is due November 21, 2022. On November 17, 2022, appellant 

filed a motion requesting a twenty-day extension of time. After consideration, we GRANT the 

motion and ORDER appellant to file its reply brief by December 12, 2022.

It is so ORDERED on November 18, 2022.

PER CURIAM

ATTESTED TO: _________________________

 MICHAEL A. CRUZ, 

 CLERK OF COURT
#### SUZANNE BUBROSKY *v.*HARRISON BUBROSKY

*Samuel V. Schoonmaker TV,*in support of the petition.

*George J. Markley,*in opposition.

Decided July 14, 2010

The plaintiffs petition for certification for appeal from the Appellate Court (AC 31977) is denied.